The feasibility of stereotactic body proton beam therapy for pancreatic cancer

HIGHLIGHTS

  • who: Hyunju Shin and colleagues from the Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine have published the Article: The Feasibility of Stereotactic Body Proton Beam Therapy for Pancreatic Cancer, in the Journal: Cancers 2022, 4556 of /2022/
  • what: The authors aimed to analyse the efficacy and safety of SBPT in pancreatic cancer.
  • how: This result is consistent with that of a previous study that emphasises the importance of induction chemotherapy .
  • future: Future studies should focus on developing an optimal scheme for chemotherapy and SBPT in terms . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?